Medicare PBM Accountability Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Medicare PBM Accountability Act is a House bill introduced in the 118th Congress aimed at addressing issues related to pharmacy benefit managers (PBMs) within the Medicare program. The bill's goal is to increase accountability and oversight of PBMs to ensure they operate transparently and in the best interest of Medicare beneficiaries. As of the latest update, the bill has been referred to the Subcommittee on Health but has not progressed further and is currently classified as failed or expired. No official summary or full text is available to provide detailed provisions or mechanisms of the bill.
This bill sought to enhance oversight of PBMs in Medicare but did not advance beyond initial committee referral and is now expired.
- The bill focuses on increasing accountability for pharmacy benefit managers within Medicare.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- The bill did not progress and is currently marked as failed or expired.
['Medicare beneficiaries who may receive improved transparency and potentially better management of prescription drug benefits', 'Regulatory bodies overseeing Medicare and PBMs', 'Healthcare providers and pharmacies involved in Medicare prescription drug plans']
['Lack of detailed bill text limits understanding of specific implementation mechanisms and enforcement provisions', 'Potential costs associated with increased oversight and regulatory compliance for PBMs', 'Unclear authority and scope of regulatory changes due to absence of full legislative language', "Oversight challenges if the bill's provisions are not clearly defined or funded"]
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance beyond this stage and is now classified as failed or expired. The policy area is health, specifically focusing on Medicare and pharmacy benefit managers. No further legislative action or debate details are available.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased administrative burden on PBMs and Medicare administrators if accountability measures require new reporting or compliance processes', 'Possible changes in prescription drug pricing or availability within Medicare due to altered PBM operations', 'Impact on healthcare providers and pharmacies interacting with PBMs under Medicare plans']
The absence of a full bill text and official summary limits transparency and comprehensive oversight analysis. The bill's failure to advance past subcommittee referral suggests limited legislative momentum. Future transparency efforts would benefit from access to complete legislative language and detailed summaries to assess policy impacts and implementation feasibility.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.